Pharmafile Logo

Dedicated

National Institute for Health and Care Excellence NICE logo

NICE backs two eye treatments

Novartis’ Lucentis and Alimera’s Iluvien received green light for NHS use

- PMLiVE

Personalised cancer support app wins Janssen’s digital prize

Px HealthcareCare takes first place, ahead of DrEd and Onco Drug Personalized Med

- PMLiVE

Syros appoints Moderna CEO to board

Stéphane Bancel also has experience at bioMérieux and Lilly

Perry Evans joins PiR Resourcing

Takes up client services director post at Cambridgeshire firm

- PMLiVE

Pharma should not ignore India

It’s complicated, but multinational pharma cannot ignore a market with one billion plus people

- PMLiVE

Melinta names chief medical officer

Sue Cammarata has experience at Shire and Novartis

- PMLiVE

ViiV’s Tivicay for HIV on course for EU approval

More positive news for GSK, Pfizer and Shionogi joint venture

- PMLiVE

BMS/AZ’s diabetes drug among CHMP recommendations

Xigduo one of six new drugs backed in EU

Bayer symbol

Bayer offers $2.4bn to buy Xofigo partner Algeta

Norwegian firm says negotiations still at 'an early stage'

- PMLiVE

Nexavar cleared for thyroid cancer by FDA

Bayer and Onyx win expansion of oncology drug’s use in US

- PMLiVE

New hire for Heart+Mind

The strategic market research and consulting firm has appointed John Clark

- PMLiVE

Langland leads Global Award winners

UK firm wins ‘agency of the year’ for the third time in a row at international healthcare marketing awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links